Eyeing opthalmic products: Bioequivalence assessment and drug development - Strategic considerations.
Asian Journal of Pharmaceutics (AJP),
[S. l.], v. 3, n. 2, 2014. DOI:
10.22377/ajp.v3i2.303. DisponÃvel em:
http://www.asiapharmaceutics.info/index.php/ajp/article/view/303. Acesso em: 15 apr. 2026.